Due diligenceMarket accessReimbursementPartnerships
Government
Government Strategy & Non-Dilutive Funding
Federal pathways, grants, and public-private strategy.
SBIR/STTRARPA-HNIHBARDAProcurement
Health
Women's Health
A strategic health, innovation, and investment priority.
InnovationInvestmentPolicyHealth equity
Core
Healthcare Strategy
Policy, capital, care, and implementation — the thread that connects it all.
PolicyCapitalCareImplementation
02
The Journey
Every chapter shaped how she thinks about healthcare, strategy, and reinvention.
2025 — Present
Founder & General Partner
Niche Defense Ventures
Emerging venture fund at the intersection of women's health and dual-use defense technology, built on a policy-first playbook for the federal health continuum.
2023 — Present
Healthcare Investor & Advisor
HIP
Collaborative early-stage diligence and investment across digital health, AI, and life sciences with 195+ investors.
2023 — Present
Board of Directors
Hemp for Victory
Co-led the national petition to reschedule cannabis from Schedule I to III; clinical and policy frameworks that informed the 2025 Executive Order on cannabis research.
2022 — Present
Board of Directors
Texas e-Health Alliance
The state's leading advocate for health IT, telemedicine, and remote monitoring to improve the healthcare system for patients.
2019 — Present
CEO & Founder
Curativo Enterprises LLC
Federal market-entry strategy for health IT and biotech across DoD, VA, IHS, and BOP; designed the CMS Prescription Digital Therapy category and the national billing standards for digital health reimbursement.
Foundations
PharmD · MAJ, U.S. Army (Ret.)
Clinical pharmacy & military medicine
The clinical depth and operational discipline underneath every chapter that followed.
Speaking Topics
Defense Health Innovation→
Healthcare Investment→
Commercialization→
Government Funding→
Women's Health→
Artificial Intelligence→
Digital Twins→
Cybersecurity→
Healthcare Policy→
Emerging Therapeutics→
Cannabis→
Longevity→
Peptide Medicine→
Precision Medicine→
03
Writing
Perspectives on pharmacy leadership, healthcare innovation, and strategy. The Journal ↗
In development — vote for what she should write next.
Defense Health—
Why Defense Health Innovation Is Shaping the Future of Medicine
Explore how military medicine, dual-use technologies, and national security investments are accelerating breakthroughs that ultimately improve civilian healthcare.
Defense Health—
Beyond Traditional Healthcare: The Rise of Dual-Use Defense Health Innovation and Regulated Therapeutics
Examine how defense health innovation intersects with regulated therapeutics — including cannabis, psychedelics, and other emerging therapies — and why this convergence matters for healthcare, investment, and policy.
Defense Health—
From Battlefield to Bedside: Translating Defense Innovation into Civilian Healthcare
Examine how technologies developed for military readiness transition into civilian medicine, and what barriers still prevent wider adoption.
Defense Health—
Human Performance as the Next Frontier of Healthcare
Explore how military human performance initiatives are influencing preventive medicine, rehabilitation, resilience, and healthy aging.
Digital—
Digital Twins and the Future of Healthcare
Explain how digital twins may transform personalized care, clinical decision support, disease prediction, healthcare operations, and pharmaceutical development.
Digital—
Why Cybersecurity Is Now a Patient Safety Issue
Show why cybersecurity is no longer just an IT responsibility but a core component of clinical safety, operational continuity, and trust in digital healthcare.
Digital—
Healthcare Beyond the Hospital
Examine the shift toward decentralized care, remote monitoring, AI-enabled decision support, and home-based healthcare.
Digital—
Building the Digital Infrastructure for Next-Generation Healthcare
Discuss interoperability, FHIR, AI, cloud platforms, cybersecurity, and digital biomarkers as foundational infrastructure rather than isolated technologies.
Digital—
AI Is Not the Future of Healthcare—Infrastructure Is
Argue that AI alone cannot transform healthcare without secure, interoperable, data-driven infrastructure to support it.
Therapeutics—
Regulated Therapeutics: The Next Era of Cannabis, Psychedelics, and Novel Medicines
Examine how cannabis, psychedelic-assisted therapies, ketamine, peptides, and future regulated therapeutics are reshaping clinical practice, reimbursement, regulation, and investment.
Therapeutics—
Peptide Therapeutics: Innovation, Regulation, and the Future of Personalized Medicine
Provide an evidence-based overview of peptide therapies, their expanding clinical applications, regulatory landscape, commercialization opportunities, and future role in precision medicine.
Therapeutics—
Cannabis Beyond the Headlines
Move beyond political debates to examine cannabis through the lens of healthcare delivery, regulation, patient outcomes, reimbursement, and implementation.
Therapeutics—
Psychedelic Medicine: Preparing Healthcare for the Next Generation of Behavioral Health Treatments
Explore the infrastructure, education, regulation, and clinical standards necessary for responsible adoption of psychedelic-assisted therapies.
Therapeutics—
The Missing Infrastructure for Regulated Therapeutics
Discuss the systems needed to support regulated therapeutics, including education, clinical protocols, interoperability, outcomes tracking, reimbursement, and compliance.
Longevity—
The Future of Longevity: From Lifespan to Healthspan
Explore the scientific, clinical, economic, and policy implications of longevity medicine and healthy aging, with a focus on improving quality of life rather than simply extending lifespan.
Longevity—
Precision Medicine Is Changing More Than Clinical Care
Examine how precision medicine influences healthcare economics, commercialization, reimbursement, research, and patient engagement.
Longevity—
Digital Biomarkers: The Missing Link Between AI and Personalized Care
Explain how digital biomarkers enable earlier detection, continuous monitoring, and more personalized clinical decision-making.
Investment—
The Future of Healthcare Commercialization
Examine how promising innovations move from research to real-world adoption, including commercialization strategy, reimbursement, market access, and partnerships.
Investment—
Due Diligence Beyond the Pitch Deck
Share a framework for evaluating healthcare companies beyond technology by assessing commercialization readiness, regulatory pathways, reimbursement strategy, execution risk, and market fit.
Investment—
What Family Offices Should Know About Healthcare Innovation
Explain how family offices can evaluate opportunities in healthcare by understanding clinical validation, commercialization, regulatory risk, and long-term market potential.
Investment—
Why Great Healthcare Technologies Fail
Analyze the non-technical reasons healthcare innovations fail, including commercialization, reimbursement, implementation, regulatory barriers, and adoption challenges.
Gov Strategy—
How Non-Dilutive Funding Accelerates Healthcare Innovation
Explain how federal grants, contracts, and public-private partnerships help healthcare innovators reduce risk and accelerate commercialization.
Gov Strategy—
Understanding the Federal Funding Landscape
Provide an overview of SBIR/STTR, ARPA-H, NIH, BARDA, DoD, VA, and other federal funding opportunities supporting healthcare innovation.
Gov Strategy—
Government Is the Largest Healthcare Customer—Are You Ready?
Explain what healthcare companies should know before entering government markets, including procurement, compliance, commercialization, and contracting strategies.
Women's Health—
Why Women's Health Represents a Strategic Investment Opportunity
Explore why women's health remains underfunded despite representing one of the largest unmet healthcare markets, and examine opportunities for innovation, investment, and policy.
Women's Health—
Rethinking Women's Health Through Innovation
Examine how AI, digital health, emerging therapeutics, precision medicine, and defense innovation can improve healthcare for women.
Women's Health—
Closing the Women's Health Innovation Gap
Analyze why investment, research, and commercialization have historically overlooked women's health and what needs to change.
Strategy & Policy—
Innovation Without Implementation Is Not Innovation
Argue that successful healthcare innovation depends on commercialization, reimbursement, implementation, policy, and education — not technology alone.
Strategy & Policy—
The Four Forces Shaping the Future of Healthcare
Introduce a strategic framework of innovation, commercialization, investment, and policy, and explain why understanding their interaction is essential for healthcare leaders.
Strategy & Policy—
The Healthcare Strategist's Playbook
Define what healthcare strategy means in today's environment and provide a framework for navigating complex healthcare ecosystems.
Most Requested Topics
Top 5 by reader votes · All categories
05
Interested in collaborating, booking a speaker, or exploring strategic advisory?
Defense Health
Precision Health
Cannabis
Infrastructure
